terapia con cellule staminali

Dimensione del mercato delle cellule staminali da raggiungere $15.63 Miliardi di 2025 | CAGR: 9.2%

Si prevede che il mercato globale delle cellule staminali raggiungerà i 15,63 miliardi di dollari entro 2025, crescendo a un CAGR di 9.2%, secondo un nuovo rapporto di Grand View Research, Inc. Si prevede che l'aumento degli studi di ricerca che mirano ad ampliare l'ambito di utilità dei prodotti associati guidi la crescita del mercato. Questi progetti di ricerca hanno aperto la possibilità di implementazione di diverse applicazioni cliniche di queste cellule, influenzando così i trattamenti modificanti la malattia.

Scientists are engaged in discovering novel methods to create human stem cells. This is to address the increasing demand for stem cell production for potential investigation in disease management. This factor is certainly expected to accelerate the development of regenerative medicine, thus driving industrial growth.

Inoltre, cellular therapies are recognized as the next major advancements in transforming healthcare. Firms are expanding their cellular therapy portfolio, understanding the future potential of this arena in the treatment of Parkinson’s disease, genere 1 diabete, lesioni del midollo spinale, Il morbo di Alzheimer, e altri.

In March 2016, Scientists at Michigan State University unveiled new kind of cells “induced XEN cells” from a cellular trash pile. This discovery is expected to drive advancements in regenerative medicine. Such discoveries are anticipated to bolster research and sales in this market over the forecast period.

 

Further key findings from the report suggest:

Cellule staminali adulte

dominated the market and is expected to maintain its dominance. This can be attributed to the several factors such as lower rejection rates, long term renewal property, and no ethical concerns associated with their usage

Application wise regenerative medicine is estimated to hold the substantial share of the revenue

Presence of significant number pipeline projects for regenerative medicine is expected to fuel growth in the market

Inoltre, exploding research projects have driven the need of harvesting techniques, spingendo così il progresso della tecnologia di acquisizione

R . aumentato&D attività e ingenti fondi concessi da enti finanziatori per far progredire la ricerca cellulare negli Stati Uniti. hanno portato alla gran parte del Nord America

Si prevede che un'ampia ricerca condotta a Singapore e in Giappone guidi il progresso con strade redditizie

Advanced Cell Technology Inc, Osiris Therapeutics Inc, Celgene Corporation, BIOTIME, INC., Cynata, e STEMCELL Technologies Inc., sono alcune delle principali aziende che operano in questo mercato

A number of stem cells companies

are engaged in seeking investment from overseas organizations and also developing partnerships with the pharmaceutical organizations

Grand View Research has segmented the global stem cells market on the basis of product, application, technology, terapia, and region:

Stem Cell Product Outlook (Revenue, USD Billion, 2014 – 2025)

Adult Stem Cells

Neuronal Stem Cells

Hematopoietic Stem Cells

Cellule staminali mesenchimali

Umbilical Cord Stem Cells

Others

Human Embryonic Stem Cells

Cellule staminali pluripotenti indotte

Very Small Embryonic Like Stem Cells

Stem Cell Application Outlook (Revenue, USD Billion, 2014 – 2025)

Cliniche di cellule staminali negli Stati Uniti

Neurology

Orthopedics

Oncologia

Hematology

Cardiovascular and Myocardial Infraction

Injuries

Diabete

Liver Disorder

Incontinence

Others

Drug Discovery and Development

Stem Cell Technology Outlook (Revenue, USD Billion, 2014 – 2025)

Cell Acquisition

Bone Marrow Harvest

Umbilical Blood Cord

Apheresis

Cell Production

Therapeutic Cloning

In-vitro Fertilization

Cell Culture

Isolation

vengono raccolte dai denti

Expansion and Sub-Culture

Terapia con cellule staminali Outlook (Revenue, USD Billion, 2014 – 2025)

autologo Terapia con cellule staminali

Allogenico Terapia con cellule staminali

 

To request this report, please contact Dr Eugene Zadorin

( eugene.zadorin@nbscience.com )

 

 

 


NBScienza

organizzazione di ricerca a contratto

terapia con cellule staminali